Results 341 to 350 of about 734,075 (399)

<i>Pseudomonas aeruginosa</i> aggregates elicit neutrophil swarming. [PDF]

iScience
Drenkard E, Godfrey C, Hopke A, Thundivalappil SR, Li MC, Irimia D, Hurley BP.   +6 more
europepmc   +1 more source

Modulation of pulmonary immune functions by the <i>Pseudomonas aeruginosa</i> secondary metabolite pyocyanin. [PDF]

Front Immunol
Lew SQ, Chong SY, Lau GW.
europepmc   +1 more source

Multidrug resistance of Pseudomonas aeruginosa: do virulence properties impact on resistance patterns? [PDF]

Front Microbiol
Saha P, Kabir RB, Ahsan CR, Yasmin M.
europepmc   +1 more source

Increased rates of bla_NDM in Pseudomonas aeruginosa in a tertiary care hospital in southern Brazil. [PDF]

Braz J Infect Dis
Barth PO, Pereira DC, Wilhelm CM, Tragnago KF, Barth AL.   +4 more
europepmc   +1 more source

Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials

Exploration, EarlyView.
Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment, has been emerging as a key participant and driving factor in cancer. This article reviews the latest progress in this field, including the microbial community within tumors and its pro‐cancer mechanisms, as well as the anti‐tumor strategies targeting intra‐tumoral ...
Yanan Niu, Junya Feng, Jie Ma, Tixian Xiao, Wei Yuan   +4 more
wiley   +1 more source

Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application

Exploration, EarlyView.
This perspective highlights synthetic biology‐driven antibacterial strategies, focusing on three innovative approaches: engineered bacteriophages for precision bacterial targeting, reprogrammed microbes that detect quorum‐sensing signals or metabolites to release antimicrobials, and engineering mammalian cells that recognize pathogen‐associated ...
Shun Huang, Shuihao Zhao, Haijie Zhao, Mingzhang Wen, Zhong Guo   +4 more
wiley   +1 more source

Dynamic optimization elucidates higher-level pathogenicity strategies of <i>Pseudomonas aeruginosa</i>. [PDF]

Microlife
Dimitriew W, Schuster S.
europepmc   +1 more source

Sputum Microbiota Compositions Correlate With Metabolome and Clinical Outcomes of COPD‐Bronchiectasis Association: A Prospective Cohort Study

Exploration, EarlyView.
This study aimed to determine how microbiota compositions (via 16S rRNA sequencing) correlate with clinical outcome and metabolome (via liquid chromatography/mass spectrometry) of CBA. Sputum microbiome and metabolome profiles of CBA were well separated from COPD but not bronchiectasis, partly driven by the higher abundance of Proteobacteria in CBA ...
Zhen‐feng He, Xiao‐xian Zhang, Cui‐xia Pan, Xin‐zhu Yi, Yan Huang, Chun‐lan Chen, Shan‐shan Zha, Lai‐jian Cen, Han‐qin Cai, Lei Yang, Jia‐qi Gao, Hui‐min Li, Zhen‐hong Lin, Sheng‐zhu Lin, Zhang Wang, Nan‐shan Zhong, Wei‐jie Guan   +16 more
wiley   +1 more source

Biofilm inhibition of multidrug-resistant Pseudomonas aeruginosa using green-synthesized silver nanoparticles and colistin. [PDF]

Sci Rep
Azimzadeh M, Greco G, Farmani A, Nourian A, Pourhajibagher M, Taherkhani A, Alikhani MY, Bahador A.   +7 more
europepmc   +1 more source

Bacteria produce and use redox mediators for electron transfer in microbial fuel cells [PDF]

, 2004
Boon, Nico, Denef, Vincent, Höfte, Monica, Rabaey, Korneel, Verhaege, Marc, Verstraete, Willy   +5 more
core